Safety and preliminary efficacy of percutaneous co-ablation system under local anesthesia for the treatment of malignant lung tumors: A retrospective cohort study

Co-ablation is a safe treatment for malignant lung tumors with acceptable AEs rates. The incidence of pneumothorax was comparable to that of conventional cryoablation, whereas pleural effusion and hemoptysis rates were significantly lower. Furthermore, the procedure achieved favorable local control rates and prolonged progression-free survival, particularly for small (≤3 cm) lesions.